Heart Failure

What is Heart Failure?

Heart failure is a chronic condition where the heart is unable to pump blood effectively to meet the body's needs. This can lead to a buildup of fluid in the lungs, legs, and other tissues, causing congestion and swelling.

Causes and Risk Factors

Symptoms of Heart Failure

Common symptoms include:

Diagnosis and Treatment

Diagnostic Tests

To diagnose heart failure, doctors may use:

Treatment Options

Prognosis

The prognosis for heart failure varies based on its severity and the patient’s overall health. While it is a chronic condition, proper management can improve quality of life and longevity.


References & Research

Historical Background

Heart failure as a clinical syndrome was first described by ancient physicians including Hippocrates, but the modern understanding began with Richard Lower’s work on cardiac physiology in the 17th century. The New York Heart Association (NYHA) functional classification, introduced in 1928, remains the standard framework for grading heart failure severity today.

Key Research Papers

  1. The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure (CONSENSUS). N Engl J Med. 1987;316(23):1429-1435.
  2. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure (SOLVD). N Engl J Med. 1991;325(5):293-302.
  3. Packer M, Coats AJ, Fowler MB, et al. Effect of carvedilol on survival in severe chronic heart failure (COPERNICUS). N Engl J Med. 2001;344(22):1651-1658.
  4. CIBIS-II Investigators. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet. 1999;353(9146):9-13.
  5. Pitt B, Zannad F, Remme WJ, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure (RALES). N Engl J Med. 1999;341(10):709-717.
  6. McMurray JJV, Packer M, Desai AS, et al. Angiotensin-neprilysin inhibition versus enalapril in heart failure (PARADIGM-HF). N Engl J Med. 2014;371(11):993-1004.
  7. McMurray JJV, Solomon SD, Inzucchi SE, et al. Dapagliflozin in patients with heart failure and reduced ejection fraction (DAPA-HF). N Engl J Med. 2019;381(21):1995-2008.
  8. Anker SD, Butler J, Filippatos G, et al. Empagliflozin in heart failure with a preserved ejection fraction (EMPEROR-Preserved). N Engl J Med. 2021;385(16):1451-1461.
  9. Solomon SD, McMurray JJV, Claggett B, et al. Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction (DELIVER). N Engl J Med. 2022;387(12):1089-1098.
  10. Bardy GH, Lee KL, Mark DB, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure (SCD-HeFT). N Engl J Med. 2005;352(3):225-237.
  11. Cleland JGF, Daubert JC, Erdmann E, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure (CARE-HF). N Engl J Med. 2005;352(15):1539-1549.
  12. Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure. J Am Coll Cardiol. 2022;79(17):e263-e421.
  13. McDonagh TA, Metra M, Adamo M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42(36):3599-3726.

Back to Table of Contents


Video Thumbnail

Congestive Heart Failure (CHF) Pathophysiology, Nursing, Treatment, Symptoms | Heart Failure Part 1

Video Thumbnail

Top 7 Heart Failure Treatments Proven to Improve Outcomes

Video Thumbnail

Heart Failure - Medical-Surgical (Med-Surg) - Cardiovascular System - @LevelUpRN

Video Thumbnail

Heart failure diagnosis | Circulatory System and Disease | NCLEX-RN | Khan Academy

Video Thumbnail

How to Manage Congestive Heart Failure

Video Thumbnail

An Osmosis Video: Congestive Heart Failure (CHF) Explained

Video Thumbnail

Empower Your Heart: Beating Congestive Heart Failure

Video Thumbnail

Heart Failure in Dogs: 3 NEW Holistic Treatments

Video Thumbnail

Congestive Heart Failure Signs & Symptoms (& Why They Occur)